ArticleThe Lancet. Infectious diseases2015
Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis.
Article in The Lancet. Infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
118 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review.The Lancet. Infectious diseases · 2024Pooled it
- Epidemiological modelling in refugee and internally displaced people settlements: challenges and ways forward.BMJ global health · 2022Pooled it
- Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015).BMC infectious diseases · 2017Pooled it
- A systematic review of early modelling studies of Ebola virus disease in West Africa.Epidemiology and infection · 2017Pooled it
- Modelling plant disease spread via high-resolution human mobility networks.Journal of the Royal Society, Interface · 2026Article
- Survey on mathematical modeling of infectious disease dynamics: insights and applications.BMC infectious diseases · 2026Review
- Reducing transmission in multiple settings is required to eliminate the risk of major Ebola outbreaks: a mathematical modelling study.Journal of the Royal Society, Interface · 2025Article
- Adaptive behaviour during epidemics: a social risk appraisal approach to modelling dynamics.Journal of the Royal Society, Interface · 2025Article
- BharatSim: An agent-based modelling framework for India.PLoS computational biology · 2024Article
- Agent-based modeling to estimate the impact of lockdown scenarios and events on a pandemic exemplified on SARS-CoV-2.Scientific reports · 2024Article
- Article
- The lasting influence of Ebola: a qualitative study of community-level behaviors, trust, and perceptions three years after the 2014-16 Ebola epidemic in Liberia.BMC public health · 2023Article
- Article
- Social Network Analysis of Ebola Virus Disease During the 2014 Outbreak in Sukudu, Sierra Leone.Open forum infectious diseases · 2022Article
- Article
- Collaboration-competition dilemma in flattening the COVID-19 curve.Production and operations management · 2022Article
- Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia.BMC medicine · 2022Article
- Article
- Ecohydrology 2.0.Rendiconti Lincei. Scienze fisiche e naturali · 2022Review
- When and why direct transmission models can be used for environmentally persistent pathogens.PLoS computational biology · 2021Article
58 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
Abstract
backgroundThe 2014 epidemic of Ebola virus disease in parts of west Africa defines an unprecedented health threat. We developed a model of Ebola virus transmission that integrates detailed geographical and demographic data from Liberia to overcome the limitations of non-spatial approaches in projecting the disease dynamics and assessing non-pharmaceutical control interventions.
methodsWe modelled the movements of individuals, including patients not infected with Ebola virus, seeking assistance in health-care facilities, the movements of individuals taking care of patients infected with Ebola virus not admitted to hospital, and the attendance of funerals. Individuals were grouped into randomly assigned households (size based on Demographic Health Survey data) that were geographically placed to match population density estimates on a grid of 3157 cells covering the country. The spatial agent-based model was calibrated with a Markov chain Monte Carlo approach. The model was used to estimate Ebola virus transmission parameters and investigate the effectiveness of interventions such as availability of Ebola treatment units, safe burials procedures, and household protection kits.
findingsUp to Aug 16, 2014, we estimated that 38·3% of infections (95% CI 17·4-76·4) were acquired in hospitals, 30·7% (14·1-46·4) in households, and 8·6% (3·2-11·8) while participating in funerals. We noted that the movement and mixing, in hospitals at the early stage of the epidemic, of patients infected with Ebola virus and those not infected was a sufficient driver of the reported pattern of spatial spread. The subsequent decrease of incidence at country and county level is attributable to the increasing availability of Ebola treatment units (which in turn contributed to drastically decreased hospital transmission), safe burials, and distribution of household protection kits.
interpretationThe model allows assessment of intervention options and the understanding of their role in the decrease in incidence reported since Sept 7, 2014. High-quality data (eg, to estimate household secondary attack rate, contact patterns within hospitals, and effects of ongoing interventions) are needed to reduce uncertainty in model estimates.
fundingUS Defense Threat Reduction Agency, US National Institutes of Health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.